332 related articles for article (PubMed ID: 27629428)
1. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Reis-Mendes A; Gomes AS; Carvalho RA; Carvalho F; Remião F; Pinto M; Bastos ML; Sousa E; Costa VM
Arch Toxicol; 2017 Apr; 91(4):1871-1890. PubMed ID: 27629428
[TBL] [Abstract][Full Text] [Related]
2. Autophagy (but not metabolism) is a key event in mitoxantrone-induced cytotoxicity in differentiated AC16 cardiac cells.
Reis-Mendes A; Carvalho F; Remião F; Sousa E; de Lourdes Bastos M; Costa VM
Arch Toxicol; 2023 Jan; 97(1):201-216. PubMed ID: 36216988
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial cumulative damage induced by mitoxantrone: late onset cardiac energetic impairment.
Rossato LG; Costa VM; Dallegrave E; Arbo M; Silva R; Ferreira R; Amado F; Dinis-Oliveira RJ; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
Cardiovasc Toxicol; 2014 Mar; 14(1):30-40. PubMed ID: 24096626
[TBL] [Abstract][Full Text] [Related]
4. The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity.
Rossato LG; Costa VM; de Pinho PG; Arbo MD; de Freitas V; Vilain L; de Lourdes Bastos M; Palmeira C; Remião F
Arch Toxicol; 2013 Oct; 87(10):1809-20. PubMed ID: 23545721
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event.
Rossato LG; Costa VM; Vilas-Boas V; de Lourdes Bastos M; Rolo A; Palmeira C; Remião F
Cardiovasc Toxicol; 2013 Dec; 13(4):413-25. PubMed ID: 24046265
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations.
Costa VM; Capela JP; Sousa JR; Eleutério RP; Rodrigues PRS; Dores-Sousa JL; Carvalho RA; Lourdes Bastos M; Duarte JA; Remião F; Almeida MG; Varner KJ; Carvalho F
Arch Toxicol; 2020 Dec; 94(12):4067-4084. PubMed ID: 32894303
[TBL] [Abstract][Full Text] [Related]
7. Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Brito V; Morás AM; Henriques JAP; Saffi J
Toxicol In Vitro; 2018 Oct; 52():203-213. PubMed ID: 29913208
[TBL] [Abstract][Full Text] [Related]
8. The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.
Dores-Sousa JL; Duarte JA; Seabra V; Bastos Mde L; Carvalho F; Costa VM
Toxicology; 2015 Mar; 329():106-19. PubMed ID: 25582955
[TBL] [Abstract][Full Text] [Related]
9. Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model.
Brandão SR; Reis-Mendes A; Domingues P; Duarte JA; Bastos ML; Carvalho F; Ferreira R; Costa VM
Toxicology; 2021 Jul; 459():152852. PubMed ID: 34246718
[TBL] [Abstract][Full Text] [Related]
10. The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells.
Reis-Mendes A; Carvalho F; Remião F; Sousa E; Bastos ML; Costa VM
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30862114
[TBL] [Abstract][Full Text] [Related]
11. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity of cyclophosphamide's metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes.
Dionísio F; Araújo AM; Duarte-Araújo M; Bastos ML; Guedes de Pinho P; Carvalho F; Costa VM
Arch Toxicol; 2022 Feb; 96(2):653-671. PubMed ID: 35088106
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells.
Pereira-Oliveira M; Reis-Mendes A; Carvalho F; Remião F; Bastos ML; Costa VM
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30634681
[TBL] [Abstract][Full Text] [Related]
15. Cumulative mitoxantrone-induced haematological and hepatic adverse effects in a subchronic in vivo study.
Rossato LG; Costa VM; Dallegrave E; Arbo M; Dinis-Oliveira RJ; Santos-Silva A; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):254-62. PubMed ID: 24119282
[TBL] [Abstract][Full Text] [Related]
16. Chrysin attenuates cardiomyocyte apoptosis and loss of intermediate filaments in a mouse model of mitoxantrone cardiotoxicity.
Anghel N; Cotoraci C; Ivan A; Suciu M; Herman H; Balta C; Nicolescu L; Olariu T; Galajda Z; Ardelean A; Hermenean A
Histol Histopathol; 2015 Dec; 30(12):1465-75. PubMed ID: 26112963
[TBL] [Abstract][Full Text] [Related]
17. Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.
Boran T; Akyildiz AG; Jannuzzi AT; Alpertunga B
Toxicol Lett; 2021 Jan; 336():39-49. PubMed ID: 33166663
[TBL] [Abstract][Full Text] [Related]
18. Subchronic administration of mitoxantrone and the influence of enzyme inhibitors on its induced cardiotoxicity in mice: role of NRF-2/CYP2E1.
Emeka PM; Ibrahim HIM; Alhaider IA; Morsy MA; Mohamed ME
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7806-7822. PubMed ID: 34982442
[TBL] [Abstract][Full Text] [Related]
19. The importance of drug metabolites synthesis: the case-study of cardiotoxic anticancer drugs.
Hrynchak I; Sousa E; Pinto M; Costa VM
Drug Metab Rev; 2017 May; 49(2):158-196. PubMed ID: 28393622
[TBL] [Abstract][Full Text] [Related]
20. Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells.
Reis-Mendes A; Alves M; Carvalho F; Remião F; Bastos ML; Costa VM
Interdiscip Toxicol; 2018 May; 11(1):13-21. PubMed ID: 30181708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
